Surge Private Equity Invests in Elite Clinical Network
September 8, 2023
Dallas-based Surge Private Equity formed a strategic partnership and majority investment in Elite Clinical Network (ECN), an integrated operator of phase I–IV clinical research sites across California, Arizona and Nevada. The transaction was valued at roughly $200 million and closed with debt financing provided by affiliates of MGG Investment Group LP to support ECN’s national expansion and site growth.
- Targets
- Elite Clinical Network, LLC
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.